Landos Biopharma, Inc. Annual Return On Assets in % from 2021 to 2023

Taxonomy & unit
ratio: %
Description
Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets.
Summary
Landos Biopharma, Inc. quarterly/annual Return On Assets history and growth rate from 2021 to 2023.
  • Landos Biopharma, Inc. Return On Assets for the quarter ending March 31, 2024 was -63 %, a 5.51% decline year-over-year.
  • Landos Biopharma, Inc. annual Return On Assets for 2023 was -49.1 %, a 28% increase from 2022.
  • Landos Biopharma, Inc. annual Return On Assets for 2022 was -68.2 %, a 89.2% decline from 2021.
Return On Assets, Annual (%)
Return On Assets, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -49.1 +19.1 +28% Jan 1, 2023 Dec 31, 2023
2022 -68.2 -32.2 -89.2% Jan 1, 2022 Dec 31, 2022
2021 -36 Jan 1, 2021 Dec 31, 2021
* An asterisk sign (*) next to the value indicates that the value is likely invalid.